Paradigm Diagnostics grabs $7 mln Series B
Paradigm Diagnostics, a molecular information company, has closed $7 million in Series B financing. The investors included New Sciences Ventures and Mesa Verde Venture Partners.
17 February 2017•1 min read
Paradigm Diagnostics, a molecular information company, has closed $7 million in Series B financing. The investors included New Sciences Ventures and Mesa Verde Venture Partners.
